Cirius Therapeutics
Pioneering the future of liver and metabolic disease treatment with innovative insulin sensitizers.
est. 2015
Yuanyin Bio
Pioneering the future of medicine with groundbreaking RNA technology to tackle unmet clinical needs and develop novel preventive and therapeutic solutions.
est. 2021
Cirius Therapeutics is the older company (2015 vs 2021).
Side-by-Side Comparison
| Metric | Cirius Therapeutics | Yuanyin Bio |
|---|---|---|
| Founded | ||
| Founded | 2015 older | 2021 |
| Headquarters | ||
| Headquarters | Not tracked yet | Not tracked yet |
| Employees | ||
| Employees | Not tracked yet | Not tracked yet |
| Industry | ||
| Industry | Biopharma, Biotechnology, Health and Wellness | Biopharma, Biotechnology, Pharmaceutical |
| Funding Stage | ||
| Funding Stage | Series A | Series A |
| Total Funding | ||
| Total Funding | $49.00M | $142.00M |
| Funding Rounds | ||
| Funding Rounds | 2 | 2 |
| Services | ||
| Services | Not tracked yet | Development of new pharmaceutical products, Research and application of circular RNA technology, Creation of therapeutic and preventive medicines |
| Target Customers | ||
| Target Customers | Not tracked yet | Healthcare providers, Pharmaceutical companies, Medical research institutions, Biotechnology developers |
| Taxonomy | ||
| Taxonomy | Cirius Therapeutics, Insulin Sensitizer, MSDC-0602K, Non-alcoholic Steatohepatitis, NASH Treatment, Liver Disease, Metabolic Disease, Clinical-stage Company, Phase 2b Clinical Trial, Innovative Therapies, Pathophysiology, Biopharmaceutical Industry, Clinical Research, Drug Development | RNA Technology, Circular RNA, Innovative Drugs, Therapeutic Solutions, Preventive Medicine, Unmet Clinical Needs, Drug Development, Therapeutics Pipeline, Novel Therapies, Disease Treatment, Medical Innovation, Biopharmaceuticals, Clinical Research, Disease Targeting |
| Website | ||
| Website | ciriustx.com | therorna.com |
About Cirius Therapeutics
Cirius Therapeutics is a clinical-stage company focused on developing treatments for non-alcoholic steatohepatitis (NASH). They are pioneering the future of liver and metabolic disease treatment with innovative insulin sensitizers. The company's flagship product, MSDC-0602K, a next-generation insuli...
About Yuanyin Bio
Yuanyin Bio is emerging as a disruptive force in the Biopharma, Biotechnology, and Pharmaceutical sectors with its focus on circular RNA technology. Founded in 2021, the company aims to revolutionize the medical field through its commitment to creating innovative drugs and therapies. The startup is...
We will tell you when either one moves
BounceWatch watches Cirius Therapeutics and Yuanyin Bio for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Cirius Therapeutics and Yuanyin Bio — by email.
Frequently Asked Questions
Compare Cirius Therapeutics with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Cirius Therapeutics on 12 Sep 2024, and Yuanyin Bio on 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
